Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Aligos Therapeutics, Inc. Common Stock

ALGS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ALGS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ALGS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ALGS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ALGS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ALGS holdings by institutional investors

Quarterly net insider trading by ALGS's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $60,000 Jul 18, 2026 Issue: Labor Issues/Antitrust/Workplace
  • $80,000 Apr 16, 2026 Issue: Labor Issues/Antitrust/Workplace
  • $80,000 Jan 18, 2026 Issue: Labor Issues/Antitrust/Workplace
  • $110,000 Jul 20, 2023 Issue: Labor Issues/Antitrust/Workplace

Former government officials who have lobbied for ALGS

2 former government officials from 1 congressional office at 1 lobbying firm have lobbied for ALGS, most recently Jul 18, 2026.

  • Jonathan Yarowsky Other GCHouseJudCom82-95; SACPres95-98 Formerly GCHouseJudCom82-95; SACPres95-98 · WILMER CUTLER PICKERING HALE AND DORR LLP · Jul 18, 2026
  • Eliot L. Engel
    Brian Skretny House Senior Professional Staff HFAC 2014-2021; LD Rep. Engel2014-2021; LD/Counsel Rep. Engel 2007-2012 Formerly with Eliot L. Engel · WILMER CUTLER PICKERING HALE AND DORR LLP · Jul 18, 2026

ALGS Estimated quarterly lobbying spending

ALGS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ALGS Income Statement
ALGS Balance Sheet
ALGS Cash Flow
U.S. Patents

New ALGS patent grants

  • Patent Title: Anti-viral compounds May. 19, 2026
  • Patent Title: Pyridazinone and methods of use thereof May. 19, 2026
  • Patent Title: Pyrrole compounds Apr. 14, 2026
  • Patent Title: Modified short interfering nucleic acid (sina) molecules and uses thereof Oct. 28, 2025
  • Patent Title: Methods and compositions for targeting pd-l1 Sep. 30, 2025
  • Patent Title: Bicyclic compounds Aug. 12, 2025
  • Patent Title: Anti-viral compounds Mar. 18, 2025
  • Patent Title: Modulators of thr-β and methods of use thereof Dec. 31, 2024
  • Patent Title: Modified short interfering nucleic acid (sina) molecules and uses thereof Oct. 29, 2024
  • Patent Title: Anti-viral compounds Aug. 20, 2024
  • Patent Title: Methods and compositions for targeting pd-l1 Jun. 25, 2024
  • Patent Title: Bicyclic compounds Apr. 16, 2024
  • Patent Title: Bicyclic compounds Apr. 09, 2024
  • Patent Title: Anti-viral compounds Apr. 09, 2024
  • Patent Title: Methods and compositions for targeting pd-l1 Mar. 26, 2024
  • Patent Title: Bicyclic pyridazinones and methods of use thereof Jan. 02, 2024
  • Patent Title: Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis b Dec. 19, 2023
  • Patent Title: Modulators of thr-β and methods of use thereof Dec. 12, 2023
  • Patent Title: Tricyclic compounds Nov. 21, 2023
  • Patent Title: Oxindoles and methods of use thereof Oct. 24, 2023
  • Patent Title: Modified cyclic dinucleoside compounds as sting modulators Oct. 17, 2023
  • Patent Title: 2-pyridones and methods of use thereof Oct. 17, 2023
  • Patent Title: Pyrrole compounds Oct. 03, 2023
  • Patent Title: Methods and compositions for targeting pd-l1 Sep. 19, 2023
  • Patent Title: Methods and compositions for targeting pd-l1 Sep. 19, 2023
  • Patent Title: Methods of reducing virus molecule levels Mar. 28, 2023
  • Patent Title: Bicyclic and tricyclic compounds Feb. 28, 2023
  • Patent Title: Modified short interfering nucleic acid (sina) molecules and uses thereof Jan. 10, 2023
  • Patent Title: Modified gapmer oligonucleotides and methods of use Oct. 11, 2022
  • Patent Title: Heterocyclic compounds Oct. 11, 2022
  • Patent Title: Compounds targeting prmt5 Dec. 14, 2021
  • Patent Title: Pyrrole compounds Dec. 07, 2021
  • Patent Title: S-antigen transport inhibiting oligonucleotide polymers and methods Nov. 09, 2021
  • Patent Title: Tricyclic compounds Oct. 05, 2021
  • Patent Title: Modulators of thr-β and methods of use thereof Aug. 17, 2021
  • Patent Title: Bicyclic sulfonamides Jun. 15, 2021
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to ALGS from public contracts

ALGS News

Recent insights relating to ALGS

CNBC Recommendations

Recent picks made for ALGS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ALGS

ALGS Analyst Ratings

ALGS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ALGS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ALGS stock a Buy, Sell, or Hold?

  • What is the price target for $ALGS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ALGS Top Shareholders
Shareholder
Shares Held
ALGS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ALGS stock?

  • Who owns the most shares of $ALGS stock?

  • What funds own $ALGS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ALGS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ALGS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ALGS

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

  • Address South San Francisco, CA
  • Market Cap 34.7 million
  • Employees 82
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Aligos Therapeutics, Inc. Common Stock (ALGS) Historical Stock Prices

Aligos Therapeutics, Inc. Common Stock (ALGS) closed at $5.56 on September 23, 2026. Over the past year its adjusted close ranged from $4.08 to $13.29. Daily prices go back to October 16, 2020, 1,490 trading days in all.

  • 1 month-19.77%
  • 3 months-0.27%
  • Year to date-40.34%
  • 1 year-45.76%
  • 3 years-70.78%
  • 5 years-98.59%
  • Max-98.50%
See every congressional and insider trade on the ALGS price chart

Quiver Premium charts ALGS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 5.72 5.94 5.45 5.56 5.56 35,073
Sep 22, 2026 5.57 6.30 5.22 5.68 5.68 75,686
Sep 21, 2026 5.31 5.88 5.21 5.49 5.49 125,046
Sep 18, 2026 5.15 5.25 5.01 5.24 5.24 21,340
Sep 17, 2026 5.10 5.29 5.10 5.17 5.17 21,705
Sep 16, 2026 5.01 5.13 4.93 5.05 5.05 41,651
Sep 15, 2026 5.04 5.45 4.82 4.99 4.99 34,487
Sep 14, 2026 5.17 5.27 5.02 5.04 5.04 28,021
Sep 11, 2026 5.39 5.50 5.14 5.22 5.22 37,043
Sep 10, 2026 5.38 5.48 5.21 5.33 5.33 46,071
Sep 9, 2026 5.79 6.02 5.41 5.50 5.50 33,016
Sep 8, 2026 6.21 6.34 5.62 5.76 5.76 64,235
Sep 4, 2026 6.16 6.21 6.02 6.21 6.21 20,288
Sep 3, 2026 6.22 6.48 6.07 6.22 6.22 42,077
Sep 2, 2026 6.15 6.64 6.01 6.21 6.21 55,406
Sep 1, 2026 5.76 6.22 5.61 6.09 6.09 101,644
Aug 31, 2026 6.83 6.83 5.86 5.86 5.86 98,916
Aug 28, 2026 7.03 7.10 6.64 6.91 6.91 39,072
Aug 27, 2026 7.44 7.50 6.82 7.07 7.07 80,522
Aug 26, 2026 7.37 7.72 7.04 7.51 7.51 68,947
Aug 25, 2026 6.93 7.54 6.71 7.47 7.47 93,635
Aug 24, 2026 6.61 7.00 6.40 6.93 6.93 33,224
Aug 21, 2026 6.48 6.80 6.40 6.67 6.67 52,329
Aug 20, 2026 6.77 7.01 6.35 6.44 6.44 62,498
Aug 19, 2026 6.74 7.08 6.67 6.89 6.89 77,341
Aug 18, 2026 6.50 6.84 6.48 6.76 6.76 110,130
Aug 17, 2026 6.90 7.00 6.51 6.58 6.58 50,614
Aug 14, 2026 6.77 6.97 6.58 6.89 6.89 66,999
Aug 13, 2026 6.95 7.04 6.66 6.77 6.77 95,166
Aug 12, 2026 7.38 7.55 6.75 7.00 7.00 190,605
Aug 11, 2026 7.58 7.82 7.15 7.28 7.28 237,713
Aug 10, 2026 5.74 7.71 5.73 7.65 7.65 615,784
Aug 7, 2026 5.50 6.15 5.25 5.59 5.59 335,799
Aug 6, 2026 4.18 5.60 4.18 5.51 5.51 293,475
Aug 5, 2026 4.74 4.87 4.67 4.74 4.74 71,830
Aug 4, 2026 4.68 4.81 4.61 4.75 4.75 81,446
Aug 3, 2026 4.29 4.80 4.21 4.60 4.60 134,966
Jul 31, 2026 4.46 4.46 4.15 4.23 4.23 49,132
Jul 30, 2026 4.30 4.49 4.13 4.32 4.32 99,015
Jul 29, 2026 4.20 4.41 4.14 4.25 4.25 46,213
Jul 28, 2026 4.22 4.37 3.98 4.25 4.25 93,134
Jul 27, 2026 4.09 4.27 3.98 4.08 4.08 213,037
Jul 24, 2026 4.80 4.81 4.00 4.08 4.08 203,098
Jul 23, 2026 5.05 5.20 4.60 4.69 4.69 147,916
Jul 22, 2026 5.36 5.50 5.08 5.15 5.15 58,462
Jul 21, 2026 5.21 5.80 5.21 5.44 5.44 59,163
Jul 20, 2026 5.72 5.72 5.19 5.28 5.28 85,817
Jul 17, 2026 5.70 5.85 5.60 5.74 5.74 47,415
Jul 16, 2026 5.77 6.12 5.61 5.75 5.75 54,756
Jul 15, 2026 6.01 6.05 5.75 5.77 5.77 65,307
Jul 14, 2026 6.33 6.45 5.97 6.11 6.11 102,514
Jul 13, 2026 6.54 6.58 6.16 6.36 6.36 189,230
Jul 10, 2026 6.84 6.85 6.34 6.62 6.62 109,531
Jul 9, 2026 6.68 7.08 6.52 6.77 6.77 195,735
Jul 8, 2026 5.92 6.93 5.88 6.73 6.73 404,835
Jul 7, 2026 5.91 6.30 5.50 6.09 6.09 819,925
Jul 6, 2026 5.65 6.06 5.44 5.85 5.85 3,160,306
Jul 2, 2026 5.53 5.70 5.35 5.59 5.59 90,372
Jul 1, 2026 5.72 5.85 5.43 5.45 5.45 67,281
Jun 30, 2026 5.38 5.85 5.32 5.77 5.77 104,471
Jun 29, 2026 5.53 5.69 5.34 5.43 5.43 36,157
Jun 26, 2026 5.34 5.74 5.30 5.57 5.57 54,411
Jun 25, 2026 5.63 5.79 5.48 5.50 5.50 53,738
Jun 24, 2026 5.54 5.76 5.35 5.58 5.58 41,793
Jun 23, 2026 5.61 5.94 5.48 5.65 5.65 61,457
Jun 22, 2026 5.30 5.69 5.25 5.69 5.69 103,223
Jun 18, 2026 5.25 5.44 5.16 5.28 5.28 39,806
Jun 17, 2026 5.07 5.73 5.07 5.35 5.35 156,041
Jun 16, 2026 5.08 5.12 4.98 4.99 4.99 41,316
Jun 15, 2026 5.30 5.40 5.09 5.11 5.11 87,564
Jun 12, 2026 5.20 5.55 5.20 5.28 5.28 76,681
Jun 11, 2026 5.16 5.43 4.91 5.28 5.28 50,030
Jun 10, 2026 5.12 5.31 5.07 5.16 5.16 32,523
Jun 9, 2026 5.05 5.29 4.99 5.14 5.14 81,240
Jun 8, 2026 5.01 5.05 4.91 4.96 4.96 65,297
Jun 5, 2026 5.30 5.34 4.80 4.91 4.91 128,424
Jun 4, 2026 5.31 5.50 5.18 5.34 5.34 169,188
Jun 3, 2026 5.22 5.33 5.06 5.14 5.14 51,620
Jun 2, 2026 5.36 5.55 5.01 5.25 5.25 175,652
Jun 1, 2026 5.70 5.85 5.29 5.35 5.35 192,797
May 29, 2026 5.94 5.94 5.50 5.70 5.70 106,386
May 28, 2026 5.75 5.95 5.48 5.79 5.79 196,750
May 27, 2026 5.74 5.75 5.46 5.60 5.60 93,509
May 26, 2026 5.84 5.90 5.61 5.74 5.74 79,411
May 22, 2026 5.80 6.11 5.71 5.76 5.76 136,661
May 21, 2026 5.59 5.83 5.52 5.71 5.71 85,581
May 20, 2026 5.28 5.65 5.16 5.60 5.60 132,645
May 19, 2026 5.34 5.38 5.16 5.18 5.18 111,712
May 18, 2026 5.81 5.88 5.29 5.36 5.36 167,311
May 15, 2026 6.49 6.66 5.68 5.71 5.71 179,284
May 14, 2026 6.64 6.82 6.34 6.69 6.69 214,103
May 13, 2026 6.47 6.88 6.38 6.67 6.67 120,702
May 12, 2026 6.20 6.55 6.12 6.47 6.47 95,035
May 11, 2026 6.39 6.58 6.15 6.21 6.21 136,128
May 8, 2026 6.11 6.57 5.86 6.44 6.44 318,583
May 7, 2026 6.38 6.51 5.96 6.03 6.03 94,729
May 6, 2026 6.31 6.64 6.24 6.37 6.37 150,994
May 5, 2026 6.53 6.76 6.28 6.35 6.35 80,488
May 4, 2026 6.10 6.60 6.06 6.44 6.44 119,369
May 1, 2026 6.01 6.27 5.91 6.09 6.09 207,447
Apr 30, 2026 6.00 6.23 5.96 5.99 5.99 36,902
Apr 29, 2026 6.40 6.40 5.91 5.97 5.97 120,064
Apr 28, 2026 6.49 6.58 6.22 6.29 6.29 66,363
Apr 27, 2026 6.37 6.74 6.37 6.43 6.43 140,519
Apr 24, 2026 6.24 6.59 6.00 6.40 6.40 161,996
Apr 23, 2026 6.50 6.53 5.97 6.13 6.13 256,582
Apr 22, 2026 6.55 6.85 6.30 6.51 6.51 186,055
Apr 21, 2026 6.50 6.91 6.21 6.56 6.56 231,534
Apr 20, 2026 6.68 6.80 6.45 6.51 6.51 243,266
Apr 17, 2026 7.32 7.40 6.52 6.68 6.68 829,864
Apr 16, 2026 8.08 8.66 7.33 7.66 7.66 5,903,557
Apr 15, 2026 7.54 8.20 7.18 7.42 7.42 181,731
Apr 14, 2026 8.72 8.97 8.42 8.74 8.74 77,551
Apr 13, 2026 7.92 8.79 7.92 8.64 8.64 58,543
Apr 10, 2026 7.98 8.39 7.70 8.00 8.00 25,432
Apr 9, 2026 7.80 8.06 7.77 7.94 7.94 11,851
Apr 8, 2026 8.25 8.58 7.78 7.99 7.99 50,787
Apr 7, 2026 8.14 8.56 7.61 7.90 7.90 48,642
Apr 6, 2026 7.94 8.63 7.90 8.09 8.09 58,705
Apr 2, 2026 7.47 8.00 7.33 7.97 7.97 39,566
Apr 1, 2026 7.59 7.99 7.55 7.74 7.74 62,783
Mar 31, 2026 6.73 7.57 6.73 7.43 7.43 54,837
Mar 30, 2026 6.70 6.92 6.41 6.56 6.56 37,109
Mar 27, 2026 7.05 7.06 6.56 6.66 6.66 56,231
Mar 26, 2026 7.06 7.36 6.82 7.04 7.04 57,917
Mar 25, 2026 6.94 7.38 6.76 6.96 6.96 28,398
Mar 24, 2026 7.10 7.10 6.61 6.79 6.79 45,361
Mar 23, 2026 6.82 7.14 6.80 6.87 6.87 22,678
Mar 20, 2026 7.36 7.55 6.81 6.81 6.81 58,234
Mar 19, 2026 7.00 7.44 6.95 7.34 7.34 46,605
Mar 18, 2026 7.36 7.41 6.95 6.95 6.95 28,704
Mar 17, 2026 7.66 7.75 7.29 7.30 7.30 20,314
Mar 16, 2026 7.66 8.11 7.58 7.72 7.72 34,589
Mar 13, 2026 7.56 7.90 7.50 7.57 7.57 40,680
Mar 12, 2026 7.61 7.62 7.20 7.41 7.41 22,344
Mar 11, 2026 7.29 8.00 7.29 7.57 7.57 48,984
Mar 10, 2026 6.92 7.36 6.92 7.10 7.10 34,299
Mar 9, 2026 6.94 7.30 6.56 7.03 7.03 37,320
Mar 6, 2026 6.40 7.37 6.37 6.98 6.98 87,271
Mar 5, 2026 6.80 7.01 6.38 6.66 6.66 31,864
Mar 4, 2026 6.75 7.17 6.73 6.86 6.86 41,439
Mar 3, 2026 6.75 6.92 6.50 6.85 6.85 31,127
Mar 2, 2026 6.88 7.08 6.31 6.96 6.96 94,937
Feb 27, 2026 7.36 7.38 6.95 7.03 7.03 21,963
Feb 26, 2026 6.99 7.50 6.91 7.50 7.50 25,397
Feb 25, 2026 7.06 7.10 6.73 6.94 6.94 34,079
Feb 24, 2026 7.00 7.25 6.85 7.09 7.09 20,085
Feb 23, 2026 6.85 7.19 6.58 6.94 6.94 19,238
Feb 20, 2026 7.12 7.13 6.76 6.80 6.80 16,246
Feb 19, 2026 6.73 7.18 6.59 7.12 7.12 24,528
Feb 18, 2026 6.59 7.07 6.59 6.80 6.80 21,653
Feb 17, 2026 6.97 6.97 6.23 6.68 6.68 66,187
Feb 13, 2026 7.01 7.71 6.91 6.91 6.91 50,031
Feb 12, 2026 7.60 7.60 6.99 6.99 6.99 33,657
Feb 11, 2026 7.20 7.76 6.98 7.46 7.46 76,649
Feb 10, 2026 7.24 7.73 7.17 7.18 7.18 27,753
Feb 9, 2026 7.29 7.39 7.07 7.23 7.23 16,865
Feb 6, 2026 6.70 7.46 6.70 7.32 7.32 78,081
Feb 5, 2026 7.02 7.17 6.49 6.49 6.49 73,722
Feb 4, 2026 7.50 8.00 6.81 7.07 7.07 52,875
Feb 3, 2026 7.94 8.31 7.23 7.52 7.52 56,490
Feb 2, 2026 7.98 8.39 7.76 7.95 7.95 81,199
Jan 30, 2026 7.89 8.15 7.70 8.07 8.07 40,148
Jan 29, 2026 8.13 8.17 7.70 8.12 8.12 49,471
Jan 28, 2026 8.69 8.95 8.06 8.06 8.06 80,030
Jan 27, 2026 8.40 8.66 7.97 8.59 8.59 94,293
Jan 26, 2026 8.04 8.49 7.92 8.39 8.39 78,293
Jan 23, 2026 8.87 8.99 8.02 8.12 8.12 158,828
Jan 22, 2026 7.94 8.81 7.94 8.54 8.54 123,885
Jan 21, 2026 8.13 8.99 7.77 8.00 8.00 80,965
Jan 20, 2026 7.69 8.29 7.61 8.01 8.01 83,630
Jan 16, 2026 8.29 8.64 7.94 7.94 7.94 65,988
Jan 15, 2026 9.02 9.39 8.20 8.26 8.26 86,961
Jan 14, 2026 9.23 9.34 8.80 9.05 9.05 87,481
Jan 13, 2026 8.59 9.43 8.52 9.24 9.24 47,504
Jan 12, 2026 9.00 9.06 8.39 8.71 8.71 110,074
Jan 9, 2026 10.41 10.45 9.00 9.00 9.00 88,909
Jan 8, 2026 9.65 10.49 9.61 10.33 10.33 88,859
Jan 7, 2026 8.91 9.65 8.91 9.65 9.65 64,526
Jan 6, 2026 8.35 8.90 8.35 8.76 8.76 23,148
Jan 5, 2026 9.14 10.00 8.25 8.41 8.41 145,904
Jan 2, 2026 9.32 9.67 9.13 9.13 9.13 18,217
Dec 31, 2025 9.01 9.60 9.00 9.32 9.32 54,204
Dec 30, 2025 9.57 9.91 9.12 9.12 9.12 42,943
Dec 29, 2025 9.99 10.01 9.33 9.65 9.65 57,631
Dec 26, 2025 10.50 10.50 9.85 10.11 10.11 29,597
Dec 24, 2025 9.95 10.69 9.81 10.52 10.52 45,963
Dec 23, 2025 10.64 11.03 9.90 9.95 9.95 32,688
Dec 22, 2025 10.64 11.50 10.10 10.75 10.75 48,738
Dec 19, 2025 10.32 11.04 10.32 10.68 10.68 58,447
Dec 18, 2025 10.75 11.00 10.19 10.37 10.37 53,729
Dec 17, 2025 11.69 11.91 10.45 10.63 10.63 81,981
Dec 16, 2025 11.92 12.10 11.04 11.47 11.47 65,053
Dec 15, 2025 13.43 13.69 11.45 12.00 12.00 182,620
Dec 12, 2025 11.61 13.68 11.44 13.29 13.29 194,977
Dec 11, 2025 11.30 11.63 11.20 11.51 11.51 50,884
Dec 10, 2025 11.08 11.50 10.65 11.33 11.33 88,182
Dec 9, 2025 10.73 11.17 10.49 11.08 11.08 44,805
Dec 8, 2025 10.17 10.84 10.08 10.78 10.78 59,152
Dec 5, 2025 10.12 10.26 9.84 9.99 9.99 33,843
Dec 4, 2025 9.89 10.45 9.80 10.09 10.09 69,391
Dec 3, 2025 9.20 9.99 9.14 9.87 9.87 52,705
Dec 2, 2025 9.35 9.47 9.10 9.21 9.21 98,929
Dec 1, 2025 9.37 9.92 9.18 9.30 9.30 114,285
Nov 28, 2025 9.95 9.95 9.50 9.58 9.58 26,937
Nov 26, 2025 9.47 9.98 9.47 9.86 9.86 49,379
Nov 25, 2025 9.52 9.98 9.38 9.66 9.66 92,073
Nov 24, 2025 9.21 9.58 8.69 9.52 9.52 92,494
Nov 21, 2025 8.37 9.22 8.09 9.21 9.21 97,663
Nov 20, 2025 8.43 8.63 8.07 8.26 8.26 132,226
Nov 19, 2025 8.00 8.59 8.00 8.23 8.23 92,251
Nov 18, 2025 6.95 8.19 6.94 7.92 7.92 113,034
Nov 17, 2025 6.65 7.31 6.64 7.02 7.02 57,856
Nov 14, 2025 5.88 6.73 5.81 6.66 6.66 72,032
Nov 13, 2025 6.31 6.62 5.93 6.07 6.07 73,835
Nov 12, 2025 6.73 7.00 6.35 6.46 6.46 52,699
Nov 11, 2025 6.76 6.90 6.54 6.68 6.68 68,441
Nov 10, 2025 7.21 7.30 6.68 6.88 6.88 64,095
Nov 7, 2025 6.22 7.17 6.20 7.07 7.07 76,332
Nov 6, 2025 6.88 7.30 6.10 7.10 7.10 152,561
Nov 5, 2025 7.23 7.49 7.06 7.33 7.33 75,889
Nov 4, 2025 7.38 7.72 7.10 7.21 7.21 97,810
Nov 3, 2025 8.28 8.47 7.45 7.53 7.53 80,905
Oct 31, 2025 8.18 8.76 8.07 8.25 8.25 61,374
Oct 30, 2025 8.60 8.72 8.14 8.20 8.20 67,267
Oct 29, 2025 9.28 9.38 8.52 8.61 8.61 146,450
Oct 28, 2025 9.84 10.06 9.12 9.32 9.32 129,769
Oct 27, 2025 9.79 10.06 9.52 9.77 9.77 48,614
Oct 24, 2025 9.60 10.10 9.47 9.69 9.69 52,978
Oct 23, 2025 9.95 10.30 9.25 9.49 9.49 77,125
Oct 22, 2025 10.28 10.35 9.60 9.84 9.84 110,928
Oct 21, 2025 10.52 10.89 10.18 10.49 10.49 45,304
Oct 20, 2025 10.20 10.69 10.03 10.45 10.45 72,831
Oct 17, 2025 10.53 10.80 9.66 9.99 9.99 69,309
Oct 16, 2025 10.38 11.22 10.18 10.51 10.51 248,556
Oct 15, 2025 9.61 10.44 9.45 10.38 10.38 135,933
Oct 14, 2025 9.18 9.66 9.02 9.66 9.66 116,299
Oct 13, 2025 9.44 9.78 9.08 9.47 9.47 179,944
Oct 10, 2025 10.27 10.31 9.28 9.43 9.43 115,132
Oct 9, 2025 9.90 10.36 9.79 10.21 10.21 143,293
Oct 8, 2025 9.97 10.05 9.61 9.93 9.93 62,542
Oct 7, 2025 10.40 10.65 9.66 9.84 9.84 103,887
Oct 6, 2025 10.11 10.30 9.89 10.22 10.22 54,579
Oct 3, 2025 10.18 10.18 9.60 10.07 10.07 86,985
Oct 2, 2025 10.32 10.70 10.11 10.24 10.24 40,660
Oct 1, 2025 9.96 10.44 9.60 10.29 10.29 50,137
Sep 30, 2025 9.59 9.82 9.19 9.80 9.80 51,875
Sep 29, 2025 9.78 9.97 9.15 9.62 9.62 61,474
Sep 26, 2025 9.21 9.79 8.91 9.79 9.79 55,890
Sep 25, 2025 10.50 10.50 9.17 9.36 9.36 168,015
Sep 24, 2025 10.58 11.39 10.50 10.75 10.75 141,671
Sep 23, 2025 9.57 10.50 9.47 10.25 10.25 99,187

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Aligos Therapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ALGS, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation